S&P Futures
4,159.25 +12.50 (+0.30%) Dow Futures
32,847.00 +90.00 (+0.27%) Nasdaq Futures
13,283.50 +54.75 (+0.41%) Russell 2000 Futures
1,926.70 +4.90 (+0.25%) Crude Oil
87.88 -1.13 (-1.27%) Gold
1,793.00 +1.80 (+0.10%)
NuGen Medical Devices Inc. (NGMDF)
Chart Events
Performance Outlook
| Previous Close | 0.0900 |
| Open | 0.0900 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0900 - 0.0900 |
| 52 Week Range | 0.0700 - 0.2200 |
| Volume | |
| Avg. Volume | 3,309 |
| Market Cap | 7.843M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0760 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for NGMDF
Related Research
- ACCESSWIRE
NuGen M.D. Commences Trading on OTCQB Under The Symbol 'NGMDF'
NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that, effective July 27, 2022, its common shares will commence trading on the OTCQB under the symbol NGMDF.
- ACCESSWIRE
NuGen Announces Offering and Closing of First Tranche of Private Placement
NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") announces that it has closed the first tranche of a non-brokered private placement through the issuance of 4,118,000 units ("Units") at a price of $0.10 per Unit for gross proceeds of $411,800 (the "Offering"). Each Unit is comprised of one common share ("Common Share") of the Company and one Common Share purchase warrant ("Warrant").
- ACCESSWIRE
NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System
NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that its needle-free injection system and accessories, also known as InsuJet™, has been approved by Health Canada specifically for the needle-free delivery of insulin.
